Data Foundry

Drug recalls 2021

Tinactin — Class I drug recall D-0251-2022

Terminated recall by Bayer Healthcare Pharmaceuticals Inc., reported 2021-11-24, distributed nationwide. Chemical Contamination: presence of benzene

Recall numberD-0251-2022
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBayer Healthcare Pharmaceuticals Inc., Whippany, NJ, United States
Recall initiated2021-10-01
Classified2021-11-18
Reported by FDA2021-11-24
Terminated2023-06-26
DistributedNationwide (US)
Countries outside the USCA, MX
Quantity4,990,860 cans
Reason classeschemical contamination
UPC / GTIN / UDI-DI00311017410059
NDC11523-0165, 11523-0165-03
Lot numbersCV0180B, TN003C5, TN008D1, TN008D2, TN00BKV
Expiration dates2021-12-31, 2022-10-31, 2023-01-31, 2023-03-31

Product

Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can, Labeled as (a) Product of Finland 20006101, (b) Product of Ireland 87022897, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, UPC 3 11017 41005 9, NDC 11523-0165-3.

Reason for recall

Chemical Contamination: presence of benzene

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0251-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.